These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17636011)

  • 81. The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin.
    Martin AP; Alexander-Brett JM; Canasto-Chibuque C; Garin A; Bromberg JS; Fremont DH; Lira SA
    J Immunol; 2007 Apr; 178(7):4623-31. PubMed ID: 17372021
    [TBL] [Abstract][Full Text] [Related]  

  • 82. CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes.
    Barlow SC; Langston W; Matthews KM; Chidlow JH; Kevil CG
    Am J Pathol; 2004 Dec; 165(6):1849-52. PubMed ID: 15579429
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Possibilities of pharmacological hepatopathy and correction of fat metabolism violations in diabetes mellitus type 1].
    Semenova EV
    Eksp Klin Gastroenterol; 2009; (6):138-42. PubMed ID: 20201297
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pleiotropic Effects of Simvastatin on Wound Healing in Diabetic Mice.
    Sukpat S; Israsena N; Patumraj S
    J Med Assoc Thai; 2016 Feb; 99(2):213-9. PubMed ID: 27249902
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability.
    Dworacka M; Iskakova S; Wesołowska A; Zharmakhanova G; Stelmaszyk A; Frycz BA; Jagodziński PP; Dworacki G
    Diabetes Res Clin Pract; 2018 Sep; 143():245-253. PubMed ID: 30056191
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New members of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes.
    Mensah-Brown EP; Shahin A; Al-Shamsi M; Lukic ML
    Ann N Y Acad Sci; 2006 Oct; 1079():157-60. PubMed ID: 17130548
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An improved method of 90% pancreatectomy using a low dose of streptozotocin at the pancreaticoduodenal artery results in a rapid diabetic stage in dogs.
    Morales AP; Conde EG; López MG; Valle MI; Díaz JF; Jáuregui PH
    Acta Diabetol; 2005 Dec; 42(4):153-5. PubMed ID: 16382301
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Suppressive effect of antibodies to immune response gene products on the development of low-dose streptozotocin-induced diabetes.
    Kiesel U; Kolb H
    Diabetes; 1983 Sep; 32(9):869-71. PubMed ID: 6226551
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice.
    Kolb H
    Diabetes Metab Rev; 1987 Jul; 3(3):751-78. PubMed ID: 2956075
    [No Abstract]   [Full Text] [Related]  

  • 90. Topical simvastatin: preclinical evidence for a treatment of skin inflammatory conditions.
    Otuki MF; Pietrovski EF; Cabrini DA
    J Dermatol Sci; 2006 Oct; 44(1):45-7. PubMed ID: 16759838
    [No Abstract]   [Full Text] [Related]  

  • 91. [Plasma and pancreatic levels of diphenylhydantoin and their relation to protection from chemical diabetes induced alloxan in mice].
    Espósito Avella M; Martínez M; Vergara G
    Rev Med Panama; 1981 Sep; 6(3):278-88. PubMed ID: 7036239
    [No Abstract]   [Full Text] [Related]  

  • 92. Complete protection from low-dose streptozotocin-induced diabetes in mice.
    Rossini AA; Williams RM; Appel MC; Like AA
    Nature; 1978 Nov; 276(5684):182-4. PubMed ID: 154064
    [No Abstract]   [Full Text] [Related]  

  • 93. Enhanced Survival in Mice Exposed to Ionizing Radiation by Combination of Gamma-Tocotrienol and Simvastatin.
    Pathak R; Kumar VP; Hauer-Jensen M; Ghosh SP
    Mil Med; 2019 Mar; 184(Suppl 1):644-651. PubMed ID: 30901461
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The potential use of simvastatin for cancer treatment: A review.
    Duarte JA; de Barros ALB; Leite EA
    Biomed Pharmacother; 2021 Sep; 141():111858. PubMed ID: 34323700
    [TBL] [Abstract][Full Text] [Related]  

  • 95. RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice.
    Bravo-Nuevo A; Sugimoto H; Iyer S; Fallon Z; Lucas JM; Kazerounian S; Prendergast GC; Kalluri R; Shapiro NI; Benjamin LE
    Am J Pathol; 2011 Jan; 178(1):245-52. PubMed ID: 21224061
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of simvastatin on fracture healing of type 2 diabetic rats.
    Chen X; Liu Y; Zhou Y; Liu S; Yang X; Song Y
    Panminerva Med; 2021 Sep; 63(3):392-393. PubMed ID: 31355609
    [No Abstract]   [Full Text] [Related]  

  • 97. Seasonality of birth in patients with type 1 diabetes.
    Mathieu C; van Etten E; Gysemans C; Decallonne B; Bouillon R
    Lancet; 2002 Apr; 359(9313):1248. PubMed ID: 11955565
    [No Abstract]   [Full Text] [Related]  

  • 98. Deletion of microRNA miR-146a does not prevent streptozotocin-induced murine autoimmune type 1 diabetes.
    Yin C; Weiland M; Miao ZM; Li C; Zhou L; Mi QS
    Diabetes Metab; 2016 Nov; 42(5):372-373. PubMed ID: 27133137
    [No Abstract]   [Full Text] [Related]  

  • 99. [Simvastatin, an additional drug against breast cancer?].
    Li H; Buquet C; Vannier JP; Abdoul-Azize S
    Med Sci (Paris); 2022; 38(8-9):646-647. PubMed ID: 36094232
    [No Abstract]   [Full Text] [Related]  

  • 100. Simvastatin and survival in sepsis.
    Stamm J
    Circulation; 2004 Sep; 110(12):e315; author reply e315. PubMed ID: 15381665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.